Skip to main content
. 2013 Jul 22;32(50):5582–5592. doi: 10.1038/onc.2013.277

Table 1. Correlation of FER kinase expression with clinicopathological and molecular features of invasive breast cancer.

Feature N FER expression
    Low (0-1+) N (%) High (2-3+) N (%) P-value
Histological type
 Invasive ductal cancer 320 171 (53.4) 149 (46.6)  
 Invasive lobular cancer 126 78 (61.9) 48 (38.1)  
 Other 39 23 (59.0) 16 (41.0) 0.250
         
Histological grade
 1 88 63 (71.6) 25 (28.4)  
 2 171 110 (64.3) 61 (35.7)  
 3 219 94 (42.9) 125 (57.1) <0.001
         
MAI (per 2 mm2)
 ⩽12 239 164 (68.6) 75 (31.4)  
 ⩾13 246 108 (43.9) 138 (56.1) <0.001
         
Tumour size (cm)
 ⩽2 208 134 (64.4) 74 (35.6)  
 >2 and ⩽5 220 106 (48.2) 114 (51.8)  
 >5 49 29 (59.2) 20 (40.8) 0.003
         
Lymph node status
 Negative 227 133 (58.6) 94 (41.4)  
 Positive 231 127 (55.0) 104 (45.0) 0.435
         
Invasive lobular carcinomas
 Classical 34 33 (97.1) 1 (2.9)  
 Pleomorphic 56 17 (30.4) 39 (69.6) <0.001
         
BRCA1
 Sporadic 459 266 (58.0) 193 (42.0)  
 Mutation carrier 24 6 (25.0) 18 (75.0) 0.002
         
Perou/Sorlie classification
 Luminal 391 234 (59.8) 157 (40.2)  
 HER2 driven 22 10 (45.5) 12 (54.5)  
 Basal/TN 72 28 (38.9) 44 (61.1) 0.003
         
ER
 Negative 104 44 (42.3) 60 (57.7)  
 Positive 381 228 (59.8) 153 (40.2) 0.001
         
PR
 Negative 200 106 (53.0) 94 (47.0)  
 Positive 284 165 (58.1) 119 (41.9) 0.266
         
HER2
 Negative 435 246 (56.6) 189 (43.4)  
 Positive 49 25 (51.0) 24 (49.0) 0.460
         
EGFR
 Negative 393 233 (59.3) 160 (40.7)  
 Positive 83 34 (41.0) 49 (59.0) 0.002

Abbreviations: EFGR, epidermal growth factor receptor; ER, oestrogen receptor; HER2, human epidermal growth factor receptor 2; MAI, mitotic activity index; PR, progesterone receptor; TN, triple negative.

Statistical significance estimated by χ2-test.

Statistically significant P-values are indicated in bold.